Balanced Health Botanicals, the Denver-based parent of CBDistillery, was one of the breakout brands of the post-2018 Farm Bill CBD market. CBDistillery launched in 2016 with a five-person team and reported roughly $40 million in revenue by 2018, with internal 2019 projections of $200 million. The growth story made the brand a frequent reference case in CBD marketing coverage. Seven years later, the CBD category looks different — and the brands that survived look different too. This is part of EPR’s ongoing CBD industry coverage.
The 2018–2019 Growth Story
The original case for Balanced Health Botanicals rested on three pillars.
Direct-response marketing discipline. Then-CMO Chris Van Dusen built the marketing engine around Conversion Rate Optimization and accountable paid media buying. The brand attributed 763% year-over-year growth from 2017 to 2018 and $20 million in e-commerce revenue to that approach.
The #CBDMovement trademark. The brand registered the hashtag and built a consumer-education campaign around it, leaning on digital and paid media at a time when most CBD advertising was blocked by Meta and Google.
U.S. Hemp Authority certification. Balanced Health Botanicals was one of 13 brands to receive the inaugural certified seal in 2019, positioning the parent as a quality-signal leader at a moment when CBD product trust was the central category issue.
What Happened to the CBD Category
The 2018 Farm Bill projection was a $20 billion U.S. CBD market by 2024. The actual market settled below that. BDS Analytics and other tracking firms put U.S. CBD consumer sales in the $5–6 billion range by 2024, with growth flat or declining from a 2021 peak.
Three structural problems explain the gap.
The FDA never built a pathway. CBD remains in regulatory limbo for ingestibles and dietary supplements. The agency has repeatedly declined to issue rules and has deferred to Congress, which has not acted. Brands cannot make health claims, and major retailers have stayed cautious. See FDA Hunted CBD for a Decade — and Never Built a Pathway.
Big consumer brands stayed out. The expected entry of CPG giants — Coca-Cola, Anheuser-Busch, Nestlé — into branded CBD products did not happen at scale. The regulatory uncertainty was the gating issue.
The pivot to Delta-8, Delta-9 hemp, and now CBD-cannabinoid edibles. Many CBD brands diversified into intoxicating hemp derivatives once the 2018 Farm Bill loophole was clarified by case law. The November 12, 2026 federal hemp definition change is expected to push most intoxicating hemp-derived products outside the legal federal definition. See Cannabis 2026: Schedule III and the Hemp Split.
Where Balanced Health Botanicals and CBDistillery Sit Now
CBDistillery remains one of the largest direct-to-consumer CBD brands in the United States. The brand sells full-spectrum, broad-spectrum, and CBD isolate products across tinctures, gummies, topicals, and capsules. The product line has expanded into sleep-specific formulations (CBN-CBD blends) and cannabinoid-targeted SKUs that did not exist in 2019.
The parent company, Balanced Health Botanicals, remains based in Denver. Chris Van Dusen’s role has evolved, and the executive team has turned over multiple times since 2019, consistent with the category’s consolidation cycle.
What the BHB Case Says About CBD Marketing in 2026
Three lessons carry forward.
Direct response still works in regulated categories. CBD brands locked out of Meta and Google paid-search built compounding advantages on email, SMS, affiliate, and SEO. That playbook now extends to AI Communications: CBD buyers increasingly research products inside ChatGPT, Claude, Gemini, and Perplexity, where category visibility is determined by citation share rather than ad spend. See Generative Engine Optimization.
Certification narratives age well. The U.S. Hemp Authority seal that helped position BHB in 2019 still serves as an entity reinforcement signal AI engines retrieve. Third-party certifications, COAs, and named lab partners now function as both consumer trust and retrieval anchors.
Category consolidation rewards survivors. The CBD shake-out left fewer, larger DTC operators with established compliance infrastructure. CBDistillery is one of the survivors. Newer entrants now face the additional burden of being legible to AI engines, not just to search.
Balanced Health Botanicals is the Denver-based parent company of CBDistillery, one of the largest direct-to-consumer CBD brands in the United States. The company was founded in 2016 and grew rapidly following the 2018 Farm Bill.
Is CBDistillery still in business?
Yes. CBDistillery remains an active DTC CBD brand selling full-spectrum, broad-spectrum, and isolate products across tinctures, gummies, topicals, and sleep formulations as of 2026.
How big is the U.S. CBD market in 2026?
U.S. consumer CBD sales were estimated in the $5–6 billion range in 2024, below the $20 billion projections from 2018–2019. Regulatory uncertainty around FDA pathway and the rise of intoxicating hemp derivatives reshaped the category.
Why did CBD not become a $20 billion market?
The FDA never issued a regulatory pathway for CBD as a dietary supplement or ingestible. Major CPG companies stayed out. Major retailers limited shelf space. Buyer demand also softened as novelty faded.
What does the BHB case study teach modern brands?
Direct response works in regulated categories, certification narratives age well, and consolidation favors survivors with compliance infrastructure. In 2026 those signals also drive citation share inside AI engines.
Written by
EPR Editorial Team
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
